Showing results (1431-1440 of 1,484) with videos related to
Sort By:
Pageof 149
Science Translational Medicine|February 21, 2024
Lipocalin-2 expression identifies an intestinal regulatory neutrophil population during acute graft-versus-host diseaseMarie Czech, Sophia Schneider, Nina Peltokangas, et al.Journal of Exercise Science and Fitness|January 23, 2023
Physical literacy in Europe: The current state of implementation in research, practice, and policyJohannes Carl, Anna S Bryant, Lowri C Edwards, et al.JCI Insight|February 15, 2017
An early-biomarker algorithm predicts lethal graft-versus-host disease and survivalMatthew J Hartwell, Umut Özbek, Ernst Holler, et al.Nature Cancer|January 3, 2024
Bacteria and bacteriophage consortia are associated with protective intestinal metabolites in patients receiving stem cell transplantationErik Thiele Orberg, Elisabeth Meedt, Andreas Hiergeist, et al.Blood Advances|April 20, 2022
Assessment of systemic and gastrointestinal tissue damage biomarkers for GVHD risk stratificationAaron Etra, Stephanie Gergoudis, George Morales, et al.Blood Advances|March 30, 2018
Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversityZachariah DeFilipp, Jonathan U Peled, Shuli Li, et al.Blood|September 15, 2016
Late acute graft-versus-host disease: a prospective analysis of clinical outcomes and circulating angiogenic factorsShernan G Holtan, Nandita Khera, John E Levine, et al.Blood|March 17, 2018
MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHDHannah Major-Monfried, Anne S Renteria, Attaphol Pawarode, et al.Blood Advances|April 19, 2024
Amphiregulin, ST2, and REG3α biomarker risk algorithms as predictors of nonrelapse mortality in patients with acute GVHDAaron Etra, Najla El Jurdi, Nikolaos Katsivelos, et al.Blood Advances|May 26, 2023
Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host diseaseMonzr M Al Malki, Kaitlyn London, Janna Baez, et al.Pageof 149